How technology is lowering the costs of diabetes

The ubiquity of handheld devices is allowing care providers to monitor patients with diabetes (and many other expensive diseases) and to take preemptive steps so that more expensive care later on is not necessary. Brad Coppens from One Equity Partners, Adam Blumenthal of Blue Wolf Capital Partners, and Jacques Mulder of EY, discuss the business implications of fewer hospital visits.